thymus peptide C

Thymus peptide C is a hormonal drug, derived from the thymus glands of young calves and acts as a substitute for the physiological functions of the thymus.

Signaling Pathways >> Others >> Others

Research Areas >> Others

Peptides

Thymus Peptide C antagonizes the adrenocortical hormones' effect on the lymphatic system. Thymus Peptide C works as a substitute for the physiological functions of the thymus. With T-cell deficiency, Thymus Peptide C recruits immature system cells in the bone marrow and stimulates their maturation to the fully active T-cell phase in the lymphatic system. Thymus Peptide C increases granulopoiesis and erythropoiesis by acting on the bone marrow. The preparation can be used for all diseases with primary and secondary immune system disturbances involving T-cells which are thymus dependent and for a wide range of symptoms such as chronic viral, bacterial and fungal infections; allergic and auto-immune reactions; and certain lymphoproliferative syndromes.

Captisol | Cyclosporin A | H2DCFDA | 0MPTP hydrochloride | GW4869 | Etomoxir | TD139 | Mitoquinone mesylate | GSK2795039 | JC-1 | BAPTA-AM | AP 20187 | Setanaxib (GKT137831) | D-Luciferin | Crotaline